Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-767-7 | CAS number: 2893-78-9
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 28 1984 - July 19 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Well documented guideline study The chlorinated isocyanurates (sodium dichloroisocyanurate and sodium dichloroisocyanurate dihydrate) produce free available chlorine, in the form of hypochlorous acid (HOCl) as they dissolve in water. As the equilibria involve all of the possible chlorinated isocyanurates, the toxicity of sodium dichloroisocyanurate (NaDCC) and sodium dichloroisocyanurate dihydrate (NaDCC.2H2O) will be virtually equivalent at the same available chlorine concentration. The parent compound for all chlorinated isocyanurates is isocyanuric acid (cyanuric acid). All of the chlorinated isocyanurates are essentially equivalent, once they are dissolved in water at the low concentrations at which they are used. Therefore read across from sodium dichloroisocyanurate dihydrate to troclosene sodium is considered justified.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-2 (Acute Dermal Toxicity)
- GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Sodium dichloroisocyanurate, dihydrate
- IUPAC Name:
- Sodium dichloroisocyanurate, dihydrate
- Reference substance name:
- 1,3-dichloro-1,3,5-triazine-2,4,6(1H,3H,5H)-trione sodium salt dihydrate
- Cas Number:
- 51580-86-0
- Molecular formula:
- C3Cl2N3O3.2H2O.Na
- IUPAC Name:
- 1,3-dichloro-1,3,5-triazine-2,4,6(1H,3H,5H)-trione sodium salt dihydrate
- Details on test material:
- - Name of test material (as cited in study report): Dichloroisocyanuric acid, sodium salt, dihydrate
- Physical state: White granules
- Analytical purity: A value of 100% active ingredient was assumed for dosage calculation
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Portage, Michigan, USA
- Weight at study initiation: Male initial body weights ranged from 225.6 to 275.8 g, Female initial body weights ranged from 227.8 to 267.0 g.
- Housing: Stainless steel cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: Minimum of one week
Administration / exposure
- Vehicle:
- other: acetone
- Details on dermal exposure:
- TEST MATERIAL- Amount applied: 12.25 mL/kg
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All of the rats were observed for mortality and signs of toxic and pharmalogic effects immediately after dosing, at one and four hours postdose, and once daily thereafter for 14 days. Individual body weights were recorded prior to treatment, on day 7 and at death or termination.
- Necropsy of survivors performed: yes
Results and discussion
- Preliminary study:
- The test material was applied to the skin of each rat at levles of 500, 1000, 2500 and 5000 mg/kg bw. No deaths occurred during the study. All rats appeared normal at 0, 1 and 4 hours postdose and on day 4. One male was noted as being slightly depressed on days 1, 2 and 3.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- No deaths occured during the study
- Clinical signs:
- other: All rats appeared normal at zero and one hour postdose. Slight depression was noted in all rats at four hours postdose and on days 1 and 2; persisting in one or more rats to day 7. All rats appeared normal by day 8.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Sodium dichloroisocyanurate dihydrate is not harmful by dermal exposure
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
